SEC FORM 4/A

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bailey K Thomas

(Last)

(First)

(Middle)

1618 STATION STREET

(Street)

VANCOUVER

V6A 1B6

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ANGIOTECH PHARMACEUTICALS INC [ ANPI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2011

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/16/2011

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/12/2011		J⁽¹⁾		15,000⁽¹⁾	D	$0⁽¹⁾	15,000	I	Nelson/Bailey Revocable Trust
Common Stock	05/12/2011		J⁽¹⁾		1,100⁽¹⁾	D	$0⁽¹⁾	13,900	I	Nelson/Bailey Revocable Trust
Common Stock	05/12/2011		J⁽¹⁾		13,900⁽¹⁾	D	$0⁽¹⁾	0	I	Nelson/Bailey Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option w/Tandem SAR	$1.05	05/12/2011		J⁽¹⁾			160,000⁽¹⁾	04/01/2010	03/07/2015	Common Stock	160,000	$0⁽¹⁾	700,000	D
Stock Option w/Tandem SAR	$0.27	05/12/2011		J⁽¹⁾			250,000⁽¹⁾	04/01/2009	03/09/2014	Common Stock	250,000	$0⁽¹⁾	450,000	D
Stock Option with Tandem SAR	$0.16	05/12/2011		J⁽¹⁾			250,000⁽¹⁾	01/01/2009	12/07/2013	Common Stock	250,000	$0⁽¹⁾	200,000	D
Awards	$7.65	05/12/2011		J⁽¹⁾			200,000⁽¹⁾	03/01/2007	02/01/2012	Common Stock	200,000	$0⁽¹⁾	0	D

Explanation of Responses:

1. Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were cancelled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).

Remarks:

This amendment is being filed to revise the disposal prices listed in the original Form 4 for the reporting person filed on May 16, 2011.

	/s/ David D. McMasters, Attorney-in-Fact	05/17/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.